248 related articles for article (PubMed ID: 31215628)
1. A Retrospective Cohort Study of Longitudinal Audiologic Assessment in Single and Fractionated Stereotactic Radiosurgery for Vestibular Schwannoma.
Khattab MH; Sherry AD; Whitaker R; Wharton DM; Weaver KD; Chambless LB; Cmelak AJ; Attia A
Neurosurgery; 2019 Dec; 85(6):E1078-E1083. PubMed ID: 31215628
[TBL] [Abstract][Full Text] [Related]
2. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
[TBL] [Abstract][Full Text] [Related]
3. Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
Lo A; Ayre G; Ma R; Hsu F; Akagami R; McKenzie M; Valev B; Gete E; Vallieres I; Nichol A
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):443-451. PubMed ID: 29066124
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
[TBL] [Abstract][Full Text] [Related]
5. Treatment Outcomes and Dose Rate Effects Following Gamma Knife Stereotactic Radiosurgery for Vestibular Schwannomas.
Smith DR; Saadatmand HJ; Wu CC; Black PJ; Wuu YR; Lesser J; Horan M; Isaacson SR; Wang TJC; Sisti MB
Neurosurgery; 2019 Dec; 85(6):E1084-E1094. PubMed ID: 31270543
[TBL] [Abstract][Full Text] [Related]
6. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
[TBL] [Abstract][Full Text] [Related]
7. Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: a preliminary report.
Poen JC; Golby AJ; Forster KM; Martin DP; Chinn DM; Hancock SL; Adler JR
Neurosurgery; 1999 Dec; 45(6):1299-305; discussion 1305-7. PubMed ID: 10598696
[TBL] [Abstract][Full Text] [Related]
8. Audiologic and treatment outcomes after linear accelerator-based stereotactic irradiation for acoustic neuroma.
Chung HT; Ma R; Toyota B; Clark B; Robar J; McKenzie M
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1116-21. PubMed ID: 15234046
[TBL] [Abstract][Full Text] [Related]
9. Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannomas: comparative observations of 139 patients treated at a single institution.
Puataweepong P; Dhanachai M; Dangprasert S; Narkwong L; Sitathanee C; Sawangsilpa T; Janwityanujit T; Yongvithisatid P
J Radiat Res; 2014 Mar; 55(2):351-8. PubMed ID: 24142966
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery for Koos grade IV vestibular schwannoma: a multi-institutional study.
Pikis S; Mantziaris G; Kormath Anand R; Nabeel AM; Sheehan D; Sheehan K; Reda WA; Tawadros SR; Abdelkarim K; El-Shehaby AMN; Emad Eldin R; Peker S; Samanci Y; Kaisman-Elbaz T; Speckter H; Hernández W; Isidor J; Tripathi M; Madan R; Zacharia BE; Daggubati LC; Martínez Moreno N; Martínez Álvarez R; Langlois AM; Mathieu D; Deibert CP; Sudhakar VR; Cifarelli CP; Arteaga Icaza D; Cifarelli DT; Wei Z; Niranjan A; Barnett GH; Lunsford LD; Bowden GN; Sheehan JP
J Neurosurg; 2023 Feb; 138(2):405-412. PubMed ID: 36303474
[TBL] [Abstract][Full Text] [Related]
11. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline.
Carlson ML; Jacob JT; Pollock BE; Neff BA; Tombers NM; Driscoll CL; Link MJ
J Neurosurg; 2013 Mar; 118(3):579-87. PubMed ID: 23101446
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
[TBL] [Abstract][Full Text] [Related]
13. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.
Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381
[TBL] [Abstract][Full Text] [Related]
14. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
[TBL] [Abstract][Full Text] [Related]
15. Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study.
Meijer OW; Vandertop WP; Baayen JC; Slotman BJ
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1390-6. PubMed ID: 12873685
[TBL] [Abstract][Full Text] [Related]
16. Hearing subclassification may predict long-term auditory outcomes after radiosurgery for vestibular schwannoma patients with good hearing.
Mousavi SH; Niranjan A; Akpinar B; Huang M; Kano H; Tonetti D; Flickinger JC; Dade Lunsford L
J Neurosurg; 2016 Oct; 125(4):845-852. PubMed ID: 26745482
[TBL] [Abstract][Full Text] [Related]
17. Impact of Cochlear Dose on Hearing Preservation Following Stereotactic Radiosurgery in Treatment of Vestibular Schwannomas: A Multi-Center Study.
Chang SD; Muacevic A; Klein AL; Sherman JH; Romanelli P; Santa Maria PL; Fuerweger C; Bossi Zanetti I; Beltramo G; Vaisbush Y; Tran E; Feng A; Teng H; Meola A; Gibbs I; Tolisano AM; Kutz JW; Wardak Z; Nedzi LA; Hong R; MacRae D; Sohal P; Kapoor E; Sabet-Rasekh P; Maghami S; Moncada PX; Zaleski-King A; Amdur R; Monfared A
World Neurosurg; 2023 Oct; 178():e24-e33. PubMed ID: 37268187
[TBL] [Abstract][Full Text] [Related]
18. Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss.
Rasmussen R; Claesson M; Stangerup SE; Roed H; Christensen IJ; Cayé-Thomasen P; Juhler M
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e607-11. PubMed ID: 22560549
[TBL] [Abstract][Full Text] [Related]
19. A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas.
Golfinos JG; Hill TC; Rokosh R; Choudhry O; Shinseki M; Mansouri A; Friedmann DR; Thomas Roland J; Kondziolka D
J Neurosurg; 2016 Dec; 125(6):1472-1482. PubMed ID: 27035174
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiotherapy in three weekly fractions for the management of vestibular schwannomas.
Gallogly JA; Jumaily M; Faraji F; Mikulec AA
Am J Otolaryngol; 2018; 39(5):561-566. PubMed ID: 29961654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
